Gabriel joined Stilla’s Board in early 2024 as an independent Board member. Formerly President at Polyplus group (now part of Sartorius) for 14 years (2009-2023), Founder and President at GeneSystems (2000-2008), meanwhile advisor to financial investors, Gabriel has experienced leadership, strategic decision making along with day-to-day operational management. His background mostly relates to PCR technologies and biomanufacturing of ATMPs although he also serves as Board member at a broader spectrum of companies within the biotech field.